UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026642
Receipt number R000030597
Scientific Title The Analysis for the Effect of Repetitive Transcranial Magnetic Stimulation in Depression
Date of disclosure of the study information 2017/03/22
Last modified on 2022/09/29 08:43:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Analysis for the Effect of Repetitive Transcranial Magnetic Stimulation in Depression

Acronym

rTMS

Scientific Title

The Analysis for the Effect of Repetitive Transcranial Magnetic Stimulation in Depression

Scientific Title:Acronym

rTMS

Region

Japan


Condition

Condition

Mental disorder with depressive state

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

the effects of rTMS on the brain activity in patients with depressive state were investigated

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Reduction of depression

Key secondary outcomes

Near-Infrared Spectroscopy(NIRS)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

repetitive Transcranial Magnetic Stimulation (rTMS)
4000pulses/day * 12days

Interventions/Control_2

sham stimulation
4000pulses/day * 12days

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients of mental disorder with depressive state
They were classified fulfilling the criteria of International Statistical Classification of Diseases and Related Health Problems-10 (ICD-10)

Key exclusion criteria

History of seizures
History of cerebral organic disease
History of indwelling metal in the body
History of drug abuse
Pregnant

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Yasuhiro
Middle name
Last name Kawasaki

Organization

Kanazawa Medical University

Division name

Department of Neuro-Psychiatry

Zip code

920-0293

Address

1-1, Daigaku, Uchinada-machi, Kahoku-gun, Ishikawa, 920-0293, Japan

TEL

076-286-2211

Email

psychiat@kanazawa-med.ac.jp


Public contact

Name of contact person

1st name Hiroaki
Middle name
Last name Okubo

Organization

Kanazawa Medical University

Division name

Department of Neuro-Psychiatry

Zip code

920-0293

Address

1-1, Daigaku, Uchinada-machi, Kahoku-gun, Ishikawa, 920-0293, Japan

TEL

076-286-2211

Homepage URL


Email

psychiat@kanazawa-med.ac.jp


Sponsor or person

Institute

Kanazawa Medical University
Department of Neuro-Psychiatry

Institute

Department

Personal name



Funding Source

Organization

Kanazawa Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kanazawa Medical University Hospital Clinical Reseach and Trials Center

Address

1-1, Daigaku, Uchinada-machi, Kahoku-gun, Ishikawa, 920-0293, Japan

Tel

076-218-8347

Email

tiken@kanazawa-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

金沢医科大学病院(石川県)


Other administrative information

Date of disclosure of the study information

2017 Year 03 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2017 Year 03 Month 22 Day

Date of IRB

2017 Year 03 Month 31 Day

Anticipated trial start date

2017 Year 04 Month 10 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry

2022 Year 03 Month 31 Day

Date trial data considered complete

2022 Year 03 Month 31 Day

Date analysis concluded

2023 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 03 Month 22 Day

Last modified on

2022 Year 09 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030597


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name